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Abstract: 
Course and outcome of patients with Alcohol dependence 
syndrome following community de-addiction treatment 
and a hospital based de-addiction treatment -a 
comparative study 
 
Background:  
Alcohol is causally related to over 200 illnesses, and also imposes a huge  economic 
burden on the country with absenteeism, and decreased productivity. Recently there has been 
a dramatic increase in alcohol consumption in India, with over 62.5 million users and  
10.6million being dependant users. In India we have hospital based de addiction, in tertiary 
care hospitals as the main modality of treatment for this, but outcomes are not promising., 
and not many community based studies have been done. 
 Aims: 
1. To compare the effectiveness of a community based de-addiction treatment with 
traditional traditional hospital based de-addiction offered at a psychiatric in-patient facility in 
a tertiary care centre. 
 
Methodology:  
 Patients were given de-addiction treatment at Vedapatti  RHC and followed up and 
the outcomes studied for 6 months. The outcomes were compared with patients who 
underwent de addiction treatment in the department of psychiatry at the medical college. 
Primary outcome measures were abstinent rates at the end of 6 months. The secondary 
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outcome measure included  drug compliance, duration of follow up, number of group visits 
and drinking percentage. 
 
Results: 
The socodemographic variables of the two samples were mostly comparable. The 
abstinent rates( =abstinent and = occasional lapses) at the end of 6 months were  for the 
community sample was 84% vs 50% for the hospital sample, which was  statistically 
significant(p=0.017). The community sample had longer duration of follow up, better drug 
compliance. The drinking percentage also showed significant reduction compared to baseline 
in both the groups 
 
Conclusion:  
This study shows promise in some areas, further research is needed so that it can serve 
as a new model for delivering de-addiction services. 
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Introduction: 
 Alcohol is one of the most commonly abused substances available legally. Alcohol 
use is responsible for various dire consequences both at the individual level and at the 
community level. Alcohol is causally associated with over 200 injuries and diseases. It leads 
to various behavioural problems and mental illnesses. It has been found to be causal in a 
number of non-communicable diseases such as CNS disorders, liver disease, certain cancers, 
GI problems etc. In 2012, 5.1% of the global disease burden and 3.3 million deaths were due 
to alcohol related problems. In the20-39 age group, it is estimated alcohol may contribute to 
25% of deaths either directly or indirectly (1).  
 
Apart from health problems, alcohol use also is a hindrance to the socioeconomic 
growth of the country, contributing to days of work lost, and decreased productivity. Industry 
association sources estimate that 15% to 20% of absenteeism and 40% of accidents at work 
are alcohol related (2). The annual loss due to alcohol related problems at the work place is 
estimated to be between70 000 to 80 000 million rupees.(3) There are also a lot of intangibles 
when it comes to alcohol related problems, as there are no effective  means to measure the  
psychosocial  impairment caused by alcohol. Domestic violence and an exacerbation of 
poverty secondary to alcohol have made alcohol abuse the single most important problem for 
women in India (4). 
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India has historically been considered as a relatively dry country, with low rates of 
alcohol use and abuse. It has been suggested that it could be because of two reasons: 
 under reporting of alcohol use 
 popularity of illicit country liquor,  the sales of which are unregulated 
   
Recently there has been a dramatic increase in the rates of alcohol consumption. In 
India the estimated numbers of alcohol users in 2005 were 62.5 million, with 17.4% of them 
(10.6million) being dependant (5). Though the burden of alcohol on the individual and 
community has been recognized, we are far from finding an effective means to tackle this 
debilitating problem.  A number of measures have been proposed by the WHO APDSS group 
such as levying taxes, banning advertisements, restricting sales, brief physician intervention 
etc. The WHO expert Committee on Alcohol considers early intervention and treatment for 
people with alcohol use disorders fulﬁlling three goals: 
o as a humanitarian approach to alleviate human suffering;  
o reducing alcohol consumption 
o and as a way of reducing alcohol related healthcare costs. (6) 
 
 
Treating alcohol dependence is a challenging task and requires a multimodal approach 
including psychological and pharmacological methods.  There is a wide treatment gap when 
it comes to alcohol use disorders in our country. There could be many reasons for the same: 
o lack of knowledge about the availability of services 
o accessibility issues as most de-addiction services are currently being offered in 
tertiary care centres in urban areas 
o affordability  
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o stigma associated with seeking treatment in a psychiatric setting 
 
o also research suggests that another  major reason  is that individuals with 
alcohol related  disorders do not perceive a need for treatment. (7-9)  
   Also conventional  treatment via hospital based de-addiction given in tertiary care 
centres offer only modest results ranging from  32.5% to 47.5% (17,18) .The low demand for 
these services, the perceived economic “benefits” from alcohol-taxes, fuels official apathy 
towards upgrading services in the treatment of this condition(32). 
 
Because of the poor outcome of severe alcohol dependence with conventional 
treatments, some health care professionals believe there is little point in trying to treat these 
patients. These factors also contribute to the large treatment gap. Hence there is an urgent 
need to not only sensitise health care professionals on the problems associated with alcohol 
use , but also to come up with alternate methods to treat the condition which are 
economically feasible and culturally acceptable. 
 
Treating patients with alcohol dependence in the community setting at a primary 
health care level is a potential solution to this growing problem that does away with some of 
the major obstacles to treatment as it will be more accessible, affordable, and not be 
associated with the stigma of being admitted in a psychiatric setting. We believe this could 
bring down the wide treatment gap (78%)(17) that exists in substance use disorders. 
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Rationale of the study: 
 Community de-addiction studies have been done in various parts of the country and 
have shown some promise. However they have been few and far between. Also in some 
studies, the sample was not homogenous and included patients with other substance use 
disorders(10) and in others the outcomes were not rigorously defined (14).  And there are no 
head to head studies that compare hospital based de-addiction with community based           
de-addiction.  
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Review of literature: 
  In the last couple of decades we have made great strides in understanding alcohol use 
disorders- the pathological effects of heavy drinking, its probable course, contributing factors 
both psychological and psychosocial, and about the neurobiology of addiction. This has led to 
the development of  multiple treatment options to tackle this problem- both psychological and 
pharmacological, however there is lack of general consensus on the best treatment modality 
to tackle this problem. 
Initial research in substance use disorders focussed on the setting of the de-addiction 
treatment, and compared the effectiveness of inpatient and out-patient de-addiction 
treatments. 
Project MATCH (26) was a randomized control trial done to compare the outcomes of 
out-patient and in-patient de-addiction. It was large scale study which included 952 patients 
in the out -patient arm and 774 patients in the in-patient arm. The patients were followed up 
for a year and the outcomes- percentage of days abstinent and the number of drinks on a 
drinking day in the 1 year following initial contact were analyzed. The results showed there 
was no difference in the two groups at the end of 1 year in these two outcomes.  
Finney et al (21) published a review showing better outcomes with in-patient 
treatment for substance use disorders. 
In recent times, there has been a need to compare the components of treatment and 
also the different settings in which in-patient treatment can be given for substance use 
disorders. 
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Outcome studies have been done to see the effectiveness of de-addiction treatment 
being offered in tertiary care centres in the Indian setting. 
Abraham et al (1997) (19) did a one year prospective study at JIPMER, Pondicherry 
to study the effectiveness of their de-addiction program. They recruited 60 patients with 
alcohol dependence admitted in the psychiatric ward for de-addiction treatment, which 
included detoxification, group sessions and deterrent therapy with Disulfiram. They were 
advised to follow up every two weeks after discharge. They were followed up for a year and 
the outcomes were analyzed. Mean age of the sample was 39.6 years. 54.5 % of the sample  
had a positive family history of alcohol use.  
 Out of the 60 subjects, only 9 patients were following up at the end of the year. Half 
the patients had followed up for less than 3 months and 10 patients had followed up for 
periods ranging from 3-6 months. The rest had lost follow up within a month. At the end of 
one year, one third  were abstinent; one third continued to drink but had reduced drinking 
compared to baseline and the rest continued to have unimproved drinking pattern. 
  
Chandrasekaran et al (18), 2001 did a retrospective study at JIPMER, Pondicherry to 
find out follow up rates of patients who underwent alcohol de-addiction. They studied 800  
patients with alcohol dependence who were treated over a five year period. Mean age of the 
subjects was 39.7 years (±8.66).  The sample had moderate severity of alcohol dependence 
with a mean SADQ score of 23.95.  
 Of  the  800 patients, only 28 patients (4.6%) had followed up at least for an year; 48 
patients (7.9%) had followed up  for 6-12 months and; 152 patients (25.1%) had followed up 
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for 1-6 months. Their drop-out rate within a month was as much as 62.4%, which is very high 
compared to other contemporary Indian studies. (17,19) 
 
  
Kar et al (19), 2003 carried out a one year prospective study in Kasturba Medical 
College, Manipal to look for any predictors of outcome in patients with alcohol dependence. 
They recruited 60 patients who fulfilled the criteria for alcohol dependence according to 
ICD-10,  admitted for de-addiction treatment- which includes detoxification, 
psychoeducation, aversion therapy, group therapy,  with or without disulfiram medication. 
Mean age of their sample was 42.86 years. Age of onset of regular drinking was 30.85 years. 
A majority (92%) of the  patients were prescribed disulfiram at the time of discharge and 
they were followed up for a year.   
At the end of one year 28 patients (46.7%) were abstinent. Five patients (8.3%) were 
drinking occasionally and 21 patients were having >50% drinking days. They had a drop-out 
rate of 10%. Greater age of onset of problem drinking, lower psychosocial problems were 
found to be predictors of abstinence. 
 
These figures suggest wide variability in response rates at different centres and also a 
significant proportion of patients go back to pathological drinking following discharge. 
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Chand et al (15) did an audit in NIMHANS encompassing 2735 patients who had 
attended the de-addiction clinic in 1 year. Of this 464 had fulfilled criteria for alcohol 
dependence according to ICD 10. Mean age at the time of seeking treatment was 38.1 (SD = 
9.91years). On average, a person took twelve years (12.4 ± 7.8) between the possible 
development of dependence and first consultation. A history of withdrawal seizure was 
present among 46 (10%) patients. Family history of alcohol use disorder i.e. likely 
dependence was present in 215 (46%). About half (251, 54%) the patients received long term 
medications for relapse prevention. 
 
During the one year follow up period, 50 % of the patients had not come for follow up 
following the initial assessment. Thirty percent of the patients had only one follow up after 
the initial assessment. Fourteen percent and 5.4% percent of the patients came for at least two 
and three follow up visits respectively. They had not collected any information on the patient 
who did not come for follow up visits. 
 It was observed that those who had a minimum of three follow ups were doing 
significantly better (P<0.001) (abstinent or reduced drinking) than those who had never 
reported for follow up. About 60 % of patients who visited at least once in the year had either 
remained abstinent or had reduced drinking. The study also showed that for a majority of the 
patients this was index contact at a health care setting for alcohol use and also that there was 
significant time lag between the onset of dependence and seeking of help.  
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They concluded that the role of the primary care physician in early identification 
of dependence is of paramount importance and will reduce the delay in seeking help 
and possibly prevent the development of addiction which is chronic and needs 
specialized care. There is long duration between the development of dependence and the 
patient seeking help from a mental health care facility. It is during this window that 
primary health care physicians can effectively intervene. There is a need to train 
primary care doctors to identify and manage alcohol use disorders. 
 
Murthy.P et al (16) studied the effect of continued care in patients with alcohol 
dependence. Two groups of patients were recruited from the slums of Bengaluru and they 
underwent the same de-addiction treatment. The study group also received weekly 
continued care in the community, either at a clinic located within the slum or through 
home visits. The control group was given routine hospital follow-up visits. Both groups were 
evaluated using standard questionnaires about their drinking pattern, at baseline 3rd, 6th, 9th 
and 12th months. 
 
Both groups had improved and had reduced number of drinking days at 3 months 
compared to baseline, which was not statistically significant (64% vs 50%). However, at the 
end of 6,9  and 12 months, the study group had continued to maintain the improvement but 
the control group showed a detiorating course which was statistically significant(53% vs 28% 
at the end of 12 months).  
  They had concluded that continued care seemed to significantly improve long 
term outcomes in patients with alcohol dependence. 
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Humphreys et al (27) wanted to study the effect of using community and social 
resources and outcomes of alcohol dependence. They had recruited 628 patients with alcohol 
dependence who were never treated-from detoxification units, alcoholism information and 
referral services.  395 (68.2%) patients were followed up at 3 years and 8 years later. The 
results showed that the duration of in-patient stay in the first 3 years did not predict better 
outcomes at 8 years, however more the number of out-patient visits in the initial 3 years had 
predicted better outcomes at 8 years viz lesser drinking rates  
They concluded that for a chronic disease like alcohol dependence, any short 
term intervention was unlikely to produce any impact on long term outcomes, and also 
social and community resources which are available for a long term will produce good 
outcomes in these patients.  
 
Treating patients on a camp basis started in India in the 1970s and the 1980s. It has 
worked well for treating ophthalmological conditions, offering sterilisation procedures and in 
implementing immunization programs. 
 
The first paper on camp based services for substance use disorders was published in 
1988 by Purohit and Razdan, who had detoxified patients with opioid dependence in a camp 
setting. 
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Shanthi Ranganathan et al (14) published the first paper on community alcohol        
de-addiction in India. They had treated about 105 patients over 4 years in a rural hamlet in 
South India. Though they had reported improvement rates of 85%, the outcomes as to what 
constituted improvement were not clearly defined. 
 
 Chavan et al 2003, (20) did a study in PGIMER, Chandigarh comparing the outcomes 
of de-addiction being offered in camp setting with that being offered in a hospital setting. 
They had recruited 67 patients with substance dependence in the study group (community) 
and 44 patients with substance dependence in the comparison group (hospital). However the 
sample was not homogenous as a large proportion of patients had diagnosis of opioid 
dependence rather than alcohol dependence. They were provided de-addiction and were 
evaluated at time of discharge and 3 months after discharge. Disulfiram therapy was initiated 
in 5 of 36 patients in the study group and 4 of 18 patients in comparison group.  
 
Age at presentation in the community group (38.7, SD 12.29 years) was significantly 
higher than in the comparison group (32.3, SD 9.05 years). At the end of 3 months, 43 
(64.2%) patients from the camp setting were abstinent and 18 (40.9%) from the hospital 
sample were abstinent however the difference was not statistically significant. The authors also 
noted that standard screening instruments were not used, and since consumption of natural 
opiates and alcohol was culturally accepted in that part of the country, the results couldn’t be 
generalized. 
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The same authors had published another study in 2005, where they had studied the 
outcomes of community de-addiction. They had recruited 46 patients with a history of substance 
use. Again the sample was heterogenous and included alcohol(23), opiates(20), cannabis( 2), 
sedative/hypnotic(1). They were admitted in 2 different community camps for 10 days and then were 
followed up in community outreach clinics in the respective villages.  
Thirty six patients had (78.3%) completed 6 months follow-up. Six month abstinent 
rate was 22%, however the authors report that 50% of patients reported a decrease in drug 
usage which was also taken as good outcome measure. 
 
A review by Kohn et al (17) to evaluate the utilisation of psychiatric services in low 
and middle income countries found that among all mental illnesses, alcohol abuse and 
dependence had the widest treatment gap at 78.1%. They also noted that this could be an 
understatement due to the scarcity of information available from these countries. A majority 
of the patients with alcohol use disorders do not receive any treatment, as they seek help for 
initial alcohol-related issues from primary health care providers who are not well trained to 
recognise the problem. And even if they do get help, it is after a decade when they finally 
receive some treatment, by which time the disease has become more severe. 
 
A review published by Benegal at al (32) recommends a stepped up approach to treat 
de-addiction where each step involves a more complex intervention requiring more 
specialised care. The steps they  mention are listed below. 
 
 
30 
 
Step 1  
is to recognize alcohol problems in the primary health care and general hospital 
settings 
 Step 2  
is treating harmful drinking/abuse in primary care setting   
Step 3  
is treating  moderate-to-severe dependence in primary health care settings in 
collaboration with tertiary care centres 
  Step 4  
is treatment by a psychiatrist  
Step 5  
is inpatient treatment at a centre offering specialist care. 
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Aims and Objectives: 
Aim: 
To compare the effectiveness of a community based de-addiction treatment with 
traditional traditional hospital based de-addiction offered at a psychiatric in-patient facility in 
a tertiary care centre. 
Objective: 
Primary outcome: 
To compare the abstinence and relapse rates during the 6 months follow-up between 
the community based de-addiction treatment group and the hospital based de-addiction 
treatment group. 
Secondary outcomes:  
To compare the drinking percentage days, drug compliance, duration of follow up and 
the number of group visits,between the two groups. 
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Methodology: 
 The salient features of the de-addiction treatments offered in the hospital and the 
community are described below: 
Community based de-addiction treatment: 
 
A community based de-addiction program was planned in a Rural Health Centre 
(RHC) run by Department of Community Medicine, PSG hospitals located in Vedapatti, this 
is located in a village which is 30kms away from our medical college. Patients who had 
drinking problems hailing from the area served by the RHC were asked to attend a screening 
camp. 
37 patients had come to attend the initial screening camp. Patients who had 
uncontrolled systemic diseases, co-morbid other substance use were referred to medical 
college hospital for further management. Of 37 patients, 34 patients were asked to attend the 
screening. 
 During the second screening held over 2 days, each patient was evaluated by a 
psychiatric resident under the supervision of a psychiatric consultant. Those who had other 
Axis I diagnoses referred to the Department of Psychiatry of our medical college for further 
management. Patient who qualified for a diagnosis of alcohol dependence based on ICD 10 
criteria were recruited for the study, after taking informed consent. Those who had been 
selected underwent lab investigations including a complete hemogram, random blood sugar, 
liver function test, and serum creatinine and patients with severe derangements were again 
referred to the PSG hospitals for further management. Of the 34 patients 25 were selected to 
undergo  de-addiction treatment. 
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The community based de-addiction was a 2 week program during which the patients 
were required to stay within the RHC campus. The care givers were required to stay with the 
patients during the day. Detoxification was done with either chlordiazepoxide or lorazepam 
based on liver function status. The dose was decided empirically due to shortage of man 
power to apply Clinical Institute Withdrawal Assessment scale. They were also started on 
parenteral thiamine and multivitamins. During the initial 4 days a psychiatric resident was 
posted at the PHC to watch for any complicated withdrawal symptoms. The remaining 10 
days the resident conducted rounds at least once during the day. 
 Patients had group sessions on the effect of alcohol on health, family and occupation 
by a mental health worker. One to one sessions were also held where each patient was 
allotted a mental health worker, and cues analysis and management, and interpersonal 
problems were discussed. Over all the treatment of the substance use problem was less 
intense compared to the treatment offered in the department of psychiatry in PSG hospitals. 
Education about Disulfiram, and getting consent for the same was done by a 
psychiatric consultant. They were monitored for side-effects and dose adjusted accordingly. 
Patients were discharged at the end of 2 weeks and asked to follow up at the PHC 1 week 
following discharge after that every 3rd Sunday in the following months 
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Hospital based program: 
  This treatment took place in the de-addiction ward belonging to the 
department of Psychiatry at the hospital. Patients with alcohol dependence syndrome 
according to ICD 10 criteria were admitted for a 2 week in patient program. It was required 
for the primary care giver to be present throughout the duration of stay. Baseline 
investigations had done include random blood glucose, complete hemogram, renal function 
test and liver function test including GGT. Patients were detoxified with benzodiazepenes 
either chlordiazepoxide or lorazepam, based on liver function status. The Clinical Institute 
Withdrawal Assessment scale was used to give symptom triggered treatment and tapered 
based on the symptom remission on a case to case basis. They were also given parenteral 
thiamine and multivitamins. 
 Following detoxification patients attended group session where topics such as 
education on the effects of alcohol on health, family and occupation, cues analysis and 
management, high risk situations were discussed. Also each patient was allotted a resident, 
who under the supervision of a consultant, provided aversion therapy, cues analysis and 
management, covert sensitization, relapse prevention strategies and anti-craving agents 
tailored to the individual patient. Patients were educated on Disulfiram and after evaluating 
patient’s motivation, if care giver could monitor the medication and if there were no 
contraindications, they were started on Disulfiram after taking consent from both the patient 
and the care given. They were evaluated if they tolerate the medication and any dose 
adjustments required are made. Following discharge they were asked to follow up at the 
hospital after a week with care giver. Further follow up was every 2 weeks for up to 2 months 
and every month there on. 
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For the purpose of the study, sociodemographic details were collected from both 
groups using a semi-structured proforma. 
Both group of patients were administered the following scales: 
 
 SADQ: 
  Severity  of alcohol Dependence Questionnaire(SADQ) is 20-item self administered 
questionnaire developed  by Edwards & Gross (1976) and Edwards (1978) (11) for assessing 
the severity of alcohol dependence. It has 5 sub scales to measure 5 components viz. Physical 
and Affective Withdrawal, Withdrawal Relief Drinking,  Alcohol Consumption, and Rapidity 
of Reinstatement. Each item is scored on 4 point scale where 0 indicates never and 4 
indicates  almost always. Its construct, face and content validity are well established and so is 
the reliability. It has been used in many studies to measure the severity of alcohol 
dependence. We used SADQ –community version which measures the severity of alcohol 
dependence in last three months. A score of greater than 30 was considered as severe alcohol 
dependence. 
 
DrInC questionnaire: 
Drinker’s Inventory of Consequences (DrInC) developed by William Miller (12), is a   
questionnaire, with different versions, both self rated and care giver rated.  It gives the 
impairment caused by drinking in various domains such as physical, inter and intra personal, 
impulse control and social responsibility. It also has some control questions to gauge if the 
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patients are being forthcoming in their responses A lifetime version of the scale (DrInC -2L ) 
and a 3 month version(DrInC -2R) are available. The 2L version of the scale measures the 
lifetime consequences of drinking while the 2R version inventories the consequences of 
drinking in the past 3 months. DrInC -2R scale was used and raw scores ranging from 0-135 
are got and based on which decile scores are obtained and the severity is rated from 1-10, 1 
being lowest and 10 being the highest.  
DrInC 2R-SOM is a 35 item questionnaire, which is rated by the spouse and the 
scoring is done similarly and raw scores and decile scores are obtained. 
 
URICA scale: 
University of Rhode Island Change Assessment Scale (URICA) is a self administered 
motivational scale, measuring patients’ readiness to change, originally developed by             
Di Clemente(13). There are 32-item,24-item and 12-item  questionnaires. There are 4 
subscales each having 8,6, and 4 items respectively. Responses are given on a 5-point Likert 
scale ranging from 1 (strong disagreement) to 5 (strong agreement). The 4 subscales measure the 
four stages pre-contemplation, contemplation, action and maintenance. The final score is got 
by adding the scores for subscales of contemplation, action and maintenance and subtracting 
the pre-contemplation scores from it. We used 12-item scale for the current study. The results 
were described in four stages : Precontemplation, Contemplation, Action and Maintenance. 
All the scales were translated into Tamil and then back translated into English to see 
for equivalence and the process was repeated till equivalence was achieved. 
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Assessments: 
 The patients from the community sample following discharge were asked to follow 
up on the third Sunday of every month at the RHC where the in-patient treatment was given, 
and the hospital sample were asked to follow up on either 2nd or 4th Saturday of every month 
at Department Psychiatry in the medical college hospital. Information was collected about 
drug compliance, any lapse of drinking and if there was a lapse, the number of drinking days, 
number of drinks on drinking days. Patients who did not attend the follow up were contacted 
over phone. Both the patient and the primary care giver were interviewed separately. 
The primary outcomes were Abstinence and relapse rates. We analyzed the outcomes 
by dividing the patients into 4 groups based on the information over the previous 4 weeks of 
assessment:  
1) Abstinence: Patient had not taken alcohol  
2) Occasional drinking: Patient had taken alcohol but not drinking every day 
 3) Daily drinking: Patient drinks alcohol every day but not during the day time 
 4) Daytime drinking: Drinking even during the day time.  
We also calculated Drinking percentage days as: Number of drinking days/Total days of 
follow-up. 
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Fig1 Flowchart Showing Methodology 
COMMUNITY SAMPLE(N=25)  HOSPITAL SAMPLE(N=18) 
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Analyses:   
Statistical analysis was conducted using SPSS version 19.0 for Windows. 
 All variables were checked for normality using the Kolmogorov-Smirnov  test. 
  We did parametric tests for the normally distributed data and did non-parametric tests 
for the rest.  We used student’s t test to compare the following normally distributed 
continuous variables: Mean time for the first drink, mean drinking days percentage, duration 
of alcohol intake, duration of daily drinking, SADQ score. 
  The following continuous variables were not normally distributed : onset of first 
drink, length of abstinence, URICA score,  length of follow-up, duration of drug compliance, 
group visits, we used Mann Whitney U test to compare the  groups. 
 Simple t test was used to compare the baseline drinking percentage with drinking 
percentage at the end of each month. 
  Chi-square test and fisher’s exact test were used to compare categorical variables: 
marital status, socio-economic status, telephone status, smoking status, other substance status, 
co-morbid medical illness, family history of alcoholism, history of withdrawal seizures, 
delirium tremens, benzodiazepine use, SADQ grade, URICA grade,  abstinence medications 
and primary outcome measures: number of patients remaining abstinent and relapsed.  
All reported p values are two tailed and the significance level was kept as p<0.05. 
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Results: 
 
1. Baseline profile of the study sample  
2. To compare the primary outcome measure, i.e abstinent rates at the end of 6 months 
3. To compare secondary outcome measures - duration of follow up, drug compliance, 
number of group visits and drinking percentage.   
 
 
There were 25 patients in the community based de-addiction treatment and 18 patients 
in the hospital based de-addiction treatment. 
 
Baseline profile of study sample: 
 
 All patients were males and the mean age of the hospital sample and the community 
sample was 36.24(SD-7.293) and  42.22 (SD-7.167) respectively, and the difference  was 
statistically significant. The community sample being younger compared to the hospital. 
More than 84 per cent of the patients were married.  
Both the groups were comparable in all the sociodemographic variables as shown in  
Table 1 
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Table 1: Baseline Sociodemographic Details Of The Study 
Sample 
 
 
 
 
 
Variable  
 
 
 
Community 
N=25(%) 
 
 
 
Hospital 
N=18(%) 
 
 
 
Significance 
Age 
 
 
 
 
Marital Status  
 36.24(SD-
7.293) 
42.22 (SD-
7.167) 
t=2.680 
(p=0.011) 
    
Married  
Unmarried 
Separated 
21 (84) 
3(12) 
1(4) 
16(89) 
2(11) 
0(0) 
 
X2=0.75 
 p=.685 
Employment  Unemployed 
Semi skilled 
Skilled 
Professional 
 
1(4) 
5(20) 
19(76) 
0(0) 
0(0) 
2(11) 
14(78) 
2(11) 
 
X2=6.7 
 p=.242 
Income <2000 
2001-8000 
8001-16000 
>16000 
1(4) 
6(24) 
17(68) 
1(4) 
0(0) 
3(16.7) 
11(61.1) 
4(22.3) 
 
X2=4.774 
P=.573 
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Baseline substance use characteristics: 
 
Smoking status: 
In the total sample, more than 80 percent of the patients were smokers, and they were 
equally distributed between the groups.   
 
Positive family history: 
A high number of patients (59%) had positive family history of alcohol use, which 
again was equally distributed between the groups. 
 
Age at daily drinking: 
Age at first drink was comparable between the groups, but the age at onset of daily 
drinking was significantly lower in the community sample 28.8 years (SD=6.3) compared to 
33.7(SD=6.4) years in the community.  
Education Illiterate 
Middle school 
High school 
Graduate and 
above 
5(20) 
20(80) 
0(0) 
0(0) 
5(28) 
4(22.) 
6(33.3) 
3(16.7) 
X2=9.11 
P=.105 
 
Medical  Illness YES 
 
NO 
5(20) 
 
20(80) 
5(27.8) 
 
13(72.2) 
X2=10.6 
P=.101 
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Duration of alcohol use 
The duration of alcohol use was longer in the hospital sample 19.44(SD=7.12), 
compared to the community sample 15.24(SD=6.54). 
The baseline substance use characteristics are given in Table 2 
 
Table 2:Baseline Substance Use Characteristics 
Variable  
 
Community 
N=25(%) 
 
Hospital 
N=18(%) 
Significance 
 
Smoking 
No 
Yes 
2(8) 
23(92) 
3(17) 
15(83) 
X2=.765 
p=.382 
 
Family History 
 
 
 
 
 
None 
Father 
Sibling 
Both 
11(44) 
5(20) 
6(24) 
3(12) 
 
7(38.9) 
3(16.7) 
6(33.3) 
2(11.1) 
X2=.426 
P=.927 
Age At First Drink  20.96(5.6) 22.78(5.7) Z =-1.23 
P=.217 
Age At Daily 
Drinking 
 28.8(6.3) 33.7(6.4)  t=2.437 
 p=0.020  
Duration Of Alcohol 
Use 
 15.24(SD=6.
54) 
19.44(7.12) t =1.975 
p=0.05 
44 
 
 
Fig2 Duration Of Alcohol Use In The Two Groups 
 
 
 
Baseline Severity Of Alcohol Dependence: 
 
 We used two scales to measure the severity of alcohol dependence.-  the SADQ scale 
and the DrInC questionnaire. 
 
SADQ: 
 
The mean SADQ scores were 20.36(SD=11.46) for the community and 26.89(10.46) 
for the hospital sample and the difference was not statistically significant. 
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SADQ Grade: 
 The grading of severity as mild, moderate and severe based on SADQ scores, were 
comparable between the two groups and did not show a statistical difference. 
 
DrInC and DrInC SOM: 
 The DrInC scores showed the hospital sample had a mean score of  70(SD=21.4) 
while the community sample had score of 53.7(SD=20.276). The difference between the 
groups was statistically significant. However the spouse rated DrInC –SOM didn’t show any  
significant difference between the groups. 
Table 3 shows the severity of alcohol dependence based on the 2 rating scales. 
 
Table3:Severity Of Alcohol Dependence 
Variable   
Community 
N=25(%) 
 
Hospital 
N=18(%) 
Significance 
SADQ  20.36(11.46) 26.89(10.46) t =1.939 
p=0.06 
SADQ Grade Mild 
 
Moderate 
 
Severe 
 
10(40) 
 
10(40) 
 
5(20) 
6(33.3) 
 
6(33.3) 
 
6(33.3) 
 
X2=4.401 
p=.11 
DrInC 2R  53.7(20.276) 70(21.4)  t=2.513 
 P=0.017 
DrInC  2R SOM  43.0(16.8) 44.9(11.85) t=4.11 
P=0.684 
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Fig 3 Comparing Severity As Measured By DrInC Scores 
 
 
 
Baseline Motivation Profile Of Study Sample:  
 
Motivation level at baseline was assessed by URICA scale. 
  
Mean URICA score of the community sample was13.66(SD=1.4), and the hospital 
sample was 8.78(SD=3.87) . It was highly statistically significant, showing the community 
sample to be better motivated than the hospital sample. 
 It was also reflected in the URICA grade as most of the patients(88%) in the 
community sample were in the action phase while only one third of the hospital sample were. 
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Table 4:Baseline Motivation Profile 
 
   
Community 
N=25(%) 
 
Hospital 
N=18(%) 
Significance 
URICA Score  13.66(SD=1.4) 8.78(SD=3.87) Z=-3.635 
P=0.01 
URICA Grade Pre Contemplation 
 
Contemplation 
 
Action 
0(0) 
 
3(12) 
 
22(88) 
 
 
6(33.3) 
 
6(33.3) 
 
6(33.3) 
X2=15.4 
p=.0001 
Fig4 Comparison Of URICA Motivation Scores 
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Fig5  Motivation Grades-Community 
 
 
Fig6  Motivation Grades Hospital 
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Treatment Variables: 
 
Duration Of Hospital Stay:  
Duration of hospital stay was 14 days in both the groups. 
 
Detoxification:  
 Only 56% of the patients in the community and 44% of patients in the hospital needed 
detoxification with benzodiazepines (chlordiazepoxide/ lorazepam) and the difference 
between the groups was not statistically significant. 
 
Complicated Withdrawal: 
 None of the patients had a complicated withdrawal during the hospital stay. 
Table5:Treatment Variables 
 
Variable  
 
Community 
N=25(%) 
 
Hospital 
N=18(%) 
Significance 
 
Duration of Hospital 
Stay(in days) 
  
14(SD=0) 
 
14(SD=0) 
 
Detoxification 
With Benzodiazepenes 
 
No 
Yes 
14(56) 
11(44) 
8(44.4) 
10(55.6) 
X2=4.505 
P=0.105 
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Abstinence Medication: 
 All the patients in the community were started on Disulfiram, while all the patients 
in the hospital sample were also on some abstinence medication, most of them on 
Disulfiram(88%) and the rest were started on baclofen. 
 
 
Table6:Abstinence Medication 
 
 
  
  
 
 
 
 There was no difference in the duration of hospital stay or in the use of 
abstinence medication between the groups.  
Complicated 
Withdrawal 
Yes 
 
No 
0(0) 
 
25(100) 
0(0) 
 
18(100) 
X2=.737 
p=.393 
Abstinence  
Medication 
 
Community 
N=25(%) 
 
Hospital 
N=18(%) 
Significance 
None 
 
Disulfiram 
 
Others 
0(0) 
 
25(100) 
 
0(0) 
0(0) 
 
16(88.9) 
 
2(11.1) 
X2=2.913 
p=0.088 
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Primary Outcome Measures: 
Primary outcome measures were: 
 1) Abstinence  
2) Occasional drinking  
3) Daily drinking  
4) Daytime drinking  
 
 Over the 6 month follow-up, 84% ( =abstinent and = occasional lapses) in 
community based de-adddiction group were abstinent compared to 50% ( =abstinent and = 
occasional lapses) in the hospital based de-addiction treatment group and this highly 
statistically significant(table 7). 
 
Table7:Overall 6 Month Outcome 
 
  
Community 
N=25(%) 
 
Hospital 
N=18(%) 
Significance 
Abstinent Rates 
 
 
Relapse Rates 
9(50) 
 
 
9(50) 
21(84) 
 
 
4(16) 
X2 = 5.37 
p=0.017 
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Fig7:Overall 6 Month Outcome 
 
 
  
 At the end of first month 100 percent of patients in the community remained 
abstinent, while 83.3 percent of the patients in the hospital remained abstinent. During the 
follow-up, the abstinent rate declined in both the groups but the abstinent rates were higher in 
the community group than the hospital group during all the assessment period. This 
difference reached statistical significance in the third and fourth month. 
  
The abstinent rates at the end of each month is given in Table 8 
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Table 8: Primary Outcome Measures- Abstinent And 
Relapse Rates During Follow Up 
 
Variable 
  
Community 
N=25(%) 
 
Hospital 
N=18(%) Significance 
1st month 
Outcome 
Abstinent 
Occasional 
Daily 
Daytime 
25(100) 
0 
0 
0 
15(83.3) 
2(11.1) 
1(5.6) 
0(0) 
X2=4.479 
p=0.107 
2nd month 
Outcome 
Abstinent 
Occasional 
Daily 
Daytime 
22(88) 
2(8) 
1(4) 
0 
11(61.1) 
4(22.2) 
2(11.1) 
1(5.6) 
X2=4.65 
p=0.199 
3rd month 
Outcome 
Abstinent 
Occasional 
Daily 
Daytime 
22(91.7) 
0 
2(8.3) 
0 
10(55.5) 
4(22.2) 
3(16.7) 
1(5.6) 
X2=9.027 
p=0.029 
4th month 
Outcome 
Abstinent 
Occasional 
Daily 
Daytime 
20 (83.3) 
2(8.3) 
2(8.3) 
0 
8(44.4) 
6(33.3) 
2(11.1) 
2(11.1) 
 
X2=8.458 
p=0.037 
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5th month 
Outcome 
Abstinent 
Occasional 
Daily 
Daytime 
18(78.3) 
2(8.7) 
3(13.0) 
0 
7(38.9) 
5(27.8) 
3(16.7) 
2(11.1) 
X2=9.46 
p=0.092 
6th month 
Outcome 
Abstinent 
Occasional 
Daily 
Daytime 
16(66.6) 
4(17.4) 
1(4.3) 
2(8.7) 
8(44.4) 
5(27.8) 
2(11.1) 
3(16.7) 
X2=3.526 
p=.474 
 
 
 
Fig 8: Abstinent Rates At The End Of Each Month 
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Secondary Outcome Measures : 
 
Onset of first drink after discharge: 
 The onset of first drink was much delayed in the community sample, 107 days 
(SD=56.27) compared to the hospital sample 58.3(32.7), and the difference was statistically 
significant. 
 
Table9: Onset Of First Drink 
 Community sample Hospital sample Significance 
Onset at first drink 107.73 
(SD=56.27) 
58.3 
(SD=32.7) 
Z=-1.942 
P=0.051 
 
Fig9 Onset Of First Drink 
 
164
90
51
26
107
58
0
20
40
60
80
100
120
140
160
180
Community Hospital
N
u
m
b
e
r 
o
f 
d
ay
s
56 
 
 
 Drug Compliance:  
 Community sample had better drug compliance compared to the hospital sample. 
Mean drug compliance in the community was 142(SD=51.5) days compared to 94.5(62.3) 
days for the hospital sample, and the difference was highly significant. 
 
Length Of Follow Up:  
 The length of follow up was longer in the community sample, 150 days(SD=45) 
compared to the hospital sample, 90.83 days(SD=58.3)  and this was statistically significant. 
 
Number Of Group Visits: 
 The community sample had more group visits, average of 5 visits compared to 3 
visits in the hospital sample, which was statistically significant. 
 
 The secondary outcome measures are shown in table 10 
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Table10: Secondary Outcome Measures 
 
  
Community 
N=25 
 
Hospital 
N=18 
Significance 
Drug Compliance 142 
SD=51.5 
94.5 
SD=62.3 
Z=-2.36 
P=0.01 
Length Of  F/U 
 
 
 
150 
SD=45 
90.83 
SD=58.3 
Z=-3.33 
P=0.001 
Group Visits 5.24 
SD=1.69 
3.06 
SD=1.43 
Z=-3.83 
P=0.0001 
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Fig10 Follow Up And Drug Compliance 
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Fig11:Number Of Group Visits  
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Drinking Percentage: 
 
 Drinking percentage was calculated for the patients who had relapsed. It was 
calculated as number of drinking days divided by number of days followed up. At the end of 
first month, none of the patients from the community sample had relapsed, hence the first 
month drinking percentage could not be compared between the two groups. 
 The number of patients relapsed in each arm showed more patients in the hospital 
sample had relapsed compared to the community sample. 
From the second to the sixth months, the drinking percentage in the community 
sample was lower when compared to the hospital sample, except in the third month when the 
community sample had a higher drinking percentage compared to the hospital sample, 
however it was not statistically significant. 
 The drinking percentages of the two groups at the end of each month are shown in the 
table11    
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Table11:Drinking Percentage For Patients Who Relapsed 
 
Variable Community Hospital Significance 
1st Month Drinking % 
 
Patients Relapsed 
 
0.00 SD=0 
 
0 
15 SD=16.41 
 
4 
 
2nd Month Drinking % 
 
 
Patients Relapsed 
 
26 SD=28.2 
 
 
3 
29 SD=20.10 
 
 
7 
 t=.147 
p=0.871 
3rd Month Drinking % 
 
 
Patients Relapsed 
 
46.05 SD=18.01 
 
 
2 
33 SD=33.45 
 
 
9 
 t=.753 
p=0.508 
4th Month Drinking % 
 
 
Patients Relapsed 
31.07  SD=33.88 
 
 
4 
37.69 SD=27.45 
 
 
12 
Z=-.425 
P=0.671 
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5th Month Drinking % 
 
Patients Relapsed 
 
38.36 SD=26.77 
 
5 
35.23 SD=32.54 
 
12 
Z=-.211 
p=0.879 
6th Month 
Drinking % 
 
Patients Relapsed 
31.7 
SD=30.6 
 
7 
37.7 
SD=32.04 
 
12 
Z=-0.635 
P=0.539 
 
 
Fig12:Drinking Percentage At The End Of Each Month 
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At the end of 6 months, 67% of the community sample and 44% of the hospital 
sample remained completely abstinent and the rest had  relapsed into drinking. Among those 
who relapsed the drinking percentage which was calculated was compared with the baseline 
drinking percentage which was 100% in both the groups. This was highly statistically 
significant.  
Table 12 :Reduction In Drinking Percentage From 
Baseline-Community 
 Drinking Percentage 
 
Percentage Reduction 
from baseline 
Significance 
Month 1 
Number relapsed=0 
   
Month 2 
Number relapsed=3 
26% 74%  p=0.024 
Month 3 
Number relapsed=2 
46% 54% p=0.148 
Month 4 
Number relapsed=4 
31% 69% p=0.020 
Month 5 
Number relapsed=5 
38% 62% p=0.007 
Month 6 
Number relapsed=7 
31% 69% p=0.024 
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Fig13:Comparison Of Drinking Percentage From 
Baseline- Community Group 
 
At the end of 1st month no patient in the community sample had relapsed. 
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Table 13:Reduction In Drinking Percentage From 
Baseline-Hospital 
 
 
 
 
 
 
 
 
 
 
 
 
 Drinking % 
 
Percentage Reduction 
from baseline 
Significance 
Month 1 
Number relapsed=4 
16% 84% p=0.002 
Month 2 
Number relapsed=7 
29% 71%  p=0.001 
Month 3 
Number relapsed=9 
33% 67% p=0.0001 
Month 4 
Number relapsed=12 
31% 69% p=0.0001 
Month 5 
Number relapsed=5 
35% 65% p=0.0001 
Month 6 
Number relapsed=7 
31% 69% p=0.024 
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Fig14:Comparison Of Drinking Percentage From 
Baseline- Hospital Group 
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Discussion: 
 
 Ours was a prospective cohort study to evaluate the outcomes of a community based 
de-addiction program and to see the feasibility of implementing such a program in a RHC 
and to compare the outcomes with hospital based de-addiction given in a tertiary care centre. 
 
We had recruited 2 groups of patients, the community and the hospital sample who 
were comparable in sociodemographic variables, except that the community sample was 
younger compared to the hospital sample(36.2 vs 42.2, p=0.011).   
 
Baseline substance use characteristics showed that the community sample had started 
drinking earlier (28.8 vs 33.7 years, p=0.020)  and they had shorter duration of drinking 
(19.44 vs 15.24 years, p=0.05) compared to the hospital sample. 
 
While baseline severity of alcohol dependence when SADQ scores were taken in to 
account, the community sample had less severe dependence, though it was not statistically 
significant. The DrInC questionnaire showed the community sample as having less severe 
dependence( 70 vs 53.7, p=0.017).  
 
 
 
68 
 
Studies(15,32,33) have shown that there is a long time gap between the onset of 
problem drinking the time patient approach a health care facility for help. When the 
delay is longer the severity of dependence reaches such a level that the patients need 
treatment in a specialised centre. Our study again confirms this finding that the patients 
who approach a hospital for de-addiction have more severe dependence for a longer 
duration, so by intervening early at primary health care level, we could prevent the 
progress of dependence to a more severe degree.   
Baseline motivation levels assessed by URICA score and grade showed the community 
sample were better motivated and most of them were in the action phase, whereas only one 
third of patients were in the action phase in the hospital sample. 
This we concede could be a potential confounding factor which could have 
influenced better outcomes in the community sample. 
 
There were no significant difference in treatment characteristics. Both the groups had 14 
days of hospital stay, all of them received some medication to maintain abstinence. 
All the patients in the community sample and a majority of the patients in the hospital 
sample were started on T.Disulfiram. A number of studies(23,24,25) have shown Disulfiram 
to be effective in maintaining abstinence and delaying the onset of first drink following 
discharge. Only 2 patients in the hospital group were not started on Disulfiram but were 
started on baclofen; this would not have affected the results. 
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Combining abstinent rates and occasional drinking rates as positive outcomes, our 6 
months study clearly shows that the community sample had significantly better outcomes 
than the hospital group (84% vs 50%, p=0.017). 
Each month assessment showed that the abstinent rate was lower in the community group 
than the hospital group throughout the 6 months period and it reached statistical significance 
in the third and fourth months. 
 
One of the secondary outcome measures was drinking percentage days. This was calculated for 
patients who had relapsed, to see if there is difference in the drinking pattern between the groups. Our 
results show no difference in the drinking percentage days at the end of each month, however 
compared to their baseline drinking percentage(100%), there was a significant decrease in their 
drinking. 
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Fig 15 Difference In Drinking Percentage From Baseline 
Of Both The Groups 
 
 
 
As we can see from the above chart, drinking percentage had more or less remained 
stable in the patients who had relapsed and there was a significant decrease in the drinking 
percentage from the baseline in both the groups. 
Secondary outcome measures show that the community sample had longer duration of 
follow up, better compliance with medication and attended more number of group session.  
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There are some promising studies (15,16,27) which show that continued care would 
improve outcomes and was more important than the duration of inpatient stay. Hence 
by having the PHC as the point of contact for patients to get de-addiction services, we 
could improve the follow up rate as we have shown in our study, and thereby improve 
outcomes. 
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Comparison With Other Studies: 
Baseline sociodemographic variables and substance use characteristics when 
compared with studies done in hospitals showed they had similar profile of alcohol use. 
Table 14 shows the alcohol use profile of patients from different published studies 
based in hospital compared to ours. 
Table14: Comparison Of Baseline Substance Use 
Characteristics With Other Hospital Based Studies 
Variable  Our Study 
Results 
Community  
Our Study 
Results 
Hospital  
Kar et al, 
2003 
Chandrasekaran et 
al 2001 
Chand et al 
2013 
Age  36.24 42.22 30.8 39.7 38.1 
Onset of  
First drink 
20.96 22.78 NA 23.18 NA 
Onset of 
daily 
drinking 
28.8 33.7 29.35 30.07 26.7 
Duration of  
Drinking 
15.24* 19.44* NA 9.71 12.4 
*Total duration of drinking 
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The presence of a positive family history of alcohol was also comparable to other 
studies.  
Table 15:Comparison Of Family History With Other Studies 
Variable  Our study 
Community 
sample  
Our study  
Hospital 
sample 
Kar et 
al, 
2003 
Chandrasekaran 
et al 2001 
Chand 
et al 
2013 
Murthy 
et al 
2009 
Family 
history 
56% 62% 66.2% 67.1% 54% 42% 
 
When treatment variables were compared with other published studies the duration of 
stay ranged from 10-14 days in the various studies, which again was similar to our study. 
  
Table16:Duration Of Hospital Stay Compared to Other 
Studies 
Variable  Our study 
  
Kar et al, 
2003 
Chavan et al 
2013 
Murthy et al 
2009 
Duration 
of stay 
In days 
14  14 10 14 
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In our study about half the patients had required detoxification with benzodiazepenes, and 
both chlodiazepoxide and lorazepam were used in both the groups. Using chlordiazepoxide in 
a camp setting where the liver function status of the patients may not be known could be 
potentially hazardous. But a study done (29) on 100 patients with alcohol dependence who 
needed detoxification, lorazepam was found to equally effective in alleviating withdrawal 
symptoms, when compared to traditional chlordiazepoxide. 
Therefore lorazepam could be safely used in detoxifying patients in the camp setting.  
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Treatment Outcomes: 
 Compared to other outcome studies, our community sample had an excellent rate and 
hospital sample had a better abstinent rate.. 
Table 17: Comparing Our Outcomes With Hospital Based Studies 
Outcome Our study  
community 
sample 
Our study  
Hospital 
sample 
Kar et al, 
2003 
Abraham et  al 
1997 
Abstinence 
rate at 
6months 
84% 50% 46.7% 32.5% 
 
Fig 16 Comparing Abstinent Rates With Other Hospital 
Based Studies 
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 Community based studies had given improvement rates at the end of the study period, 
which included both patients who were abstinent and also had reduced substance use. To 
compare with these studies we had also analysed patient who had reduced drinking rates, that 
is patients who were abstinent and those who had occasional drinking. 
Table 18 :Comparing Our Abstinent Rates With 
Community Based Studies 
*Outcomes not clearly defined 
 
 
 
 
Outcome Our study  
community 
sample 
Our study  
Hospital 
sample 
Chavan et al 
2003 
Murthy et al 
2009 
Ranganathan 
et al 
1994 
Abstinence 
rate at 
6months 
84% 50% 72.5% 59% 85%* 
77 
 
Fig17:Comparing Abstinent Rates With Other 
Community Based Studies 
*Outcomes not clearly defined. 
In the published community based studies, the sample was not homogenous, the 
methodology was not clearly described, standard scales were not used (20) and the 
outcomes were not clearly defined.(14) 
Our study shows that it is feasible to provide effective de-addiction treatment at 
primary care level, which has better outcomes compared to those delivered at  de-
addiction centres in tertiary care centres. When compared to other community de-
addiction studies, also our results fared much better. 
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Implications :   
 Substance use including alcohol is a significant health problem in our country. 
Recently there has been an alarming increase in prevalence of substance use, especially 
among women(1). Various measures have been suggested to tackle the alcohol burden in the 
community such as levying taxes, increasing the legal drinking age, limiting alcohol sales and 
even drastic measures such as prohibition, but much needs to be done at the ground level. 
  
.  Tackling the substance use disorders in general and alcohol dependence in particular 
needs a multipronged approach with specific programs tailored to deliver de-addiction 
services at primary, secondary, and tertiary levels of care, however to formulate such 
programs, there is disappointingly little research on substance use disorders in India. 
 
 Most of the available literature on outcome studies come from the West show that 
patients with alcohol dependence who undergo treatment eventually relapse, and it is prudent 
to view the disease as a chronic condition akin to medical illnesses like diabetes. Studies also 
underscore the importance of using community resources to have some kind of long term 
impact on this problem (26, 27). Other studies advocate  maintaining contact with patients 
over many  years and that would result in better long term outcomes.(30) 
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In a developing country such as ours where  two thirds of the population live in rural 
areas (28) it is not feasible to deliver the traditional form of de-addiction  given in tertiary 
care centres based mainly in urban areas. Some government funded centers do offer   these 
services but the overall efficacy of these programmes is low (5).  
 
With about 23,790 primary health centres in the country, there is already 
infrastructure in place to offer these services. Hence with proper training of health care 
workers, they could be transformed into centres offering detoxification, education and brief 
psychosocial interventions, which could change the way these disorders are perceived, reduce 
the stigma and pave the way for offering better care which is timely and thereby reducing the 
healthcare, socioeconomic and psychosocial burden of this debilitating disease.  
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Strengths And Limitations: 
 
Strengths: 
The strengths of our study are: 
 
o It was a prospective study, and the patients were followed up for 6 months. 
 
o Standard questionnaires and diagnostic tools were used. 
 
o The sociodemographic variables of the patients were comparable to those from 
other studies, hence the results could be generalized. 
 
o Outcomes of the study were clearly defined. 
 
o Efforts were taken to contact patients who had lost follow up over phone and 
information about their drinking status was obtained from both the patient and 
spouse. 
 
 
 
Limitations: 
o Our main limitation was the small sample size, due to constraint of resources 
at the PHC, only 25 patients could be included in the community sample. 
 
o Blinding of assessment could not be done. Hence there is risk of investigator 
bias, however the study protocols were adhered to strictly in order to minimise 
this. 
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o Even though there was a common alcohol de-addiction treatment model, variation in 
the clinician approach and treatment could also influence the outcome; this aspect 
was not studied by us. 
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Conclusion: 
 
 The abstinence rate in the community based de-addiction sample was better than the 
traditional de-addiction treatment offered in the hospital. Also the drug compliance, duration 
of follow up and number of group visits were significantly better in the community sample. 
There is already evidence to suggest that more number of contacts with a health care provider 
improved long term outcomes in patients with substance use disorders 
  
Thus we conclude that there are enough positives in our study to warrant further 
research with more number of patients. 
    
This modality of delivering de-addiction services could be the answer for the growing 
problem of substance use in the country. 
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Xg;Gjy; gbtk; 
       Njjp: 
 
lhf;lH. \pahk; uh. gh. R.  Mfpa ehd;.  gp.v];.Ip kUj;Jtf; fy;Yhhpapd; kdey 
kUj;Jtj; Jiwapd; fPo,; kJ mbikj; jdj;jpy; ,Ue;J tpLgl r%f kUj;Jt 
MNyhrid toq;Fjy; njhlHghd kUj;Jt Muha;r;rp Nkw;nfhs;s cs;Nsd;. 
 
vd; Ma;T topfhl;b : lhf;lH. Nfh. uFj;jkd;. NguhrphpaH kw;Wk; Jiwj; jiytH 
 
Ma;T Nkw;nfhs;tjw;fhd mbg;gil : 
ngUfp tUk; kJg;gof;fKk;,  kJtpw;F mbikahd midtUk; kUj;Jtkidf;F nrd;W 
MNyhrid ngw ,ayhj epiyik 
 
Ma;tpd; Nehf;fk; : 
kJ mBikj;jdj;jpy;  ,Ue;J tpLgl rpfpr;ir mspg;gjpy; kUj;Jt rpfpr;irAk; kUj;Jt 
MNyhridAk; Kf;fpa mk;rkhFk;.;. kJ mBikj;jdj;jhy; ghjpf;fg;gl;ltHfs;  
kUj;Jtkidapy; rpfpr;ir ngWtjw;F mDFtjpy;iy ,Nj rpfpr;iria r*fj;jpy; 
toq;Ftjhy; gyd; mjpfkhf ,Uf;Fkh vd;gij mwptNj Ma;tpd; Nehf;fk; 
 
Ma;T Nkw;nfhs;Sk; ,lk; : 
 
Ntlgl;b Muk;g Rfhjhu ikak;,  gp.v];.Ip kUj;Jtkid, Nfhak;Gj;JhH 
 
Ma;tpd;  gyd;fs; : 
 
kJ mUe;Jtjhy; Vw;gLk; jPa tpisTfisAk; kJ mUe;Jtij epWj;Jtjhy; Vw;gLk; 
ed;ikfisAk; nrhy;tjd; *yk; kJtpw;F mbik MdtHfspd;  vz;zpf;ifia 
Fiwj;J mtHfspd; cly; kw;Wk; cs;sk; rPuikg;G Mtjw;F cjTjy; 
 
,e;j Ma;tpy; fpilf;Fk; jfty;fs; Ie;J tUlq;fs; ghJfhf;fg;gLk;.  ,it NtW ve;e 
Ma;tpw;Fk; gad;gLj;jg;gl khl;lhJ.  Ve;j epiyapYk; cq;fisg; gw;wpa jfty;fs; 
ahUf;Fk; njhptpf;fg;glkhl;lhJ.  mit ,ufrpakhf itf;fg;gLk;. 
 
,e;j Ma;tpy; gq;Nfw;f xg;Gf;nfhs;Stjhy; ve;j tpjkhd gyDk; cq;fSf;Ff; 
fpilf;fhJ. 
ve;j Neuj;jpy; Ntz;LkhdhYk; Ma;tpypUe;J tpyfpf;nfhs;Sk; chpik cq;fSf;F 
cz;L. 
 
Ma;tpypUe;J tpyfpf;nfhs;tjhy; cq;fSf;F mspf;fg;gLk; rpfpr;irapy; ve;j tpj 
khw;wKk; ,Uf;fhJ. 
 
 
,e;j Muha;r;rpf;fhf cq;fsplk; rpy Nfs;tpfs; Nfl;fg;gLk;. NkYk; ,e;j Ma;tpy; gq;F 
nfhs;tJ cq;fs; nrhe;j tpUg;gk;. ,jpy; ve;j tpjf; fl;lhaKk; ,y;iy.  ePq;fs; 
tpUg;gg;gl;lhy; ,e;j Ma;tpd; KbTfs; cq;fSf;Fj; njhpag;gLj;jg;gLk;. 
 
 
Ma;thshpd; ifnahg;gk;  : 
 
Njjp      : 
 
Ma;Tf;Fl;gLgthpd; xg;Gjy; : 
 
ehd; ,e;j Muha;r;rpapd; Nehf;fk; kw;Wk; mjd; gad;dhl;bidg; gw;wp njspthfTk;. 
Tpsf;fkhfTk; njhpag;gLj;jg;glLs;Nsd;.  ,e;e Muha;r;rpapy; gq;F nfhs;sTk;.  ,e;j 
Muha;r;rpapd; kUf;Jt hPjpahd Fwpg;Gfis tUk; fhyj;jpYk; cgNahfglgLj;jpf; 
nfhs;sTk; KO kdJld; rk;kjpf;fpNwd;.   Muha;r;rpff;fhf kUj;JtH vd;dplk; 
njhiyNgrp.  ifNgrp %yk;  NgRtjw;Fk; MNyhrid toq;Ftjw;Fk; ehd; 
rk;kjpf;fpNwd;. 
 
 
Ma;Tf;Fl;gLgthpd;  ngaH. Kftup  :  
 
 
 
       ifnahg;gk;    : 
 
 
    Njjp   : 
PSG Institute of Medical Science and Research, Coimbatore 
Institutional Human Ethics Committee 
INFORMED CONSENT FORMAT FOR RESEARCH PROJECTS 
 
 
 
I , Dr.R.P.S.Shyam,  am carrying out a study on the topic Course and outcome of patients with 
Alcohol dependence syndrome following community de-addiction treatment and a 
hospital based de-addiction treatment -a comparative study as part of my / our research project 
being carried out under the  Department of PSYCHIATRY   
 
My  research guide is: Dr. G. Raghuthaman 
 
The justification for this study is: Alcohol is causally related to a number of diseases. Also there are a lot of 
intangibles when it comes to alcohol problem, as it causes a lot of psychosocial impairment. The purpose of 
the study is to evaluate a deaddiction program run at the level of the community- whether it will have better 
outcomes, and to compare the same with the IP deaddiction services in a hospital setting. 
 
 
 
 
The objectives of this study are:  
To study the course and outcomes of patients with alcohol dependence syndrome who receive 
community de-addiction program, run by departments of Psychiatry  (PSG Institute of Medical 
Sciences & Research) and compare them with patient who undergo  de-addiction at PSG hospitals.  
To look for socio-demographic or other variables which may predict the outcome 
Sample size:  
 
Study volunteers / participants are (specify population group & age group):Patients.Age group is 18 – 65 
years 
 
Location: Vedapatti RHC run by PSGIMS&R and  PSG Hospitals 
 
We request you to kindly cooperate with us in this study. We propose collect background information and 
other relevant details related to this study. We will be carrying out:  
 
Initial interview (specify approximate duration):30-45 minutes.  
 
Data collected will be stored for a period of fifteen years. We will / will not use the data as part of another 
study. 
 
Health education sessions: Number of sessions: _____________. Approximate duration of each session:  
 
______________ minutes.  
 
Clinical examination (Specify details and purpose): as part of the camp to look for any major co-
morbidities needing hospitalized care(exclusion criteria) 
 
Blood sample collection: Specify quantity of blood being drawn: ___________ml.  
 
Whether blood sample collection is part of routine procedure or for research (study) purpose:  Routine 
procedure 
 
1. Routine procedure 2. Research purpose  
 
Specify purpose, discomfort likely to be felt and side effects, if any: _______________________________ 
 
Whether blood sample collected will be stored after study period: Yes / No, it will be destroyed 
 
Whether blood sample collected will be sold: Yes / No  
 
Whether blood sample collected will be shared with persons from another institution: Yes / No 
 
Medication given, if any, duration, side effects, purpose, benefits:  
 
Whether medication given is part of routine procedure: Yes  
 
Whether alternatives are available for medication given: No  
 
Final interview (specify approximate duration):30-45 mts.  
 
Benefits from this study: to evaluate the effectiveness of a community deaddiction program, and to see if 
can be a viable model for further studies. To see if there can be any predictors of outcome. 
 
Risks involved by participating in this study: nil 
 
How the results will be used:  
 
If you are uncomfortable in answering any of our questions during the course of the interview / biological 
sample collection, you have the right to withdraw from the interview / study at anytime. You have the 
freedom to withdraw from the study at any point of time. Kindly be assured that your refusal to participate or 
withdrawal at any stage, if you so decide, will not result in any form of compromise or discrimination in the 
services offered nor would it attract any penalty. You will continue to have access to the regular services 
offered to a patient. You will NOT be paid any remuneration for the time you spend with us for this interview 
/ study. The information provided by you will be kept in strict confidence. Under no circumstances shall we 
reveal the identity of the respondent or their families to anyone. The information that we collect shall be 
used for approved research purposes only. You will be informed about any significant new findings - 
including adverse events, if any, – whether directly related to you or to other participants of this study, 
developed during the course of this research which may relate to your willingness to continue participation. 
 
Consent: The above information regarding the study, has been read by me/ read to me, and has been 
explained to me by the investigator/s. Having understood the same, I hereby give my consent to them to 
interview me. I am affixing my signature / left thumb impression to indicate my consent and willingness to 
participate in this study (i.e., willingly abide by the project requirements).  
 
Signature / Left thumb impression of the Study Volunteer / Legal Representative:  
 
 
Signature of the Interviewer with date:      Witness: 
Contact number of PI: 9566147375 
Contact number of Ethics Committee Office:  0422 2570170 Extn.: 5818 
Socio-demographic data 
Name: 
Address: 
Phone no.:   Spouse: 
 
Age:  Sex: 
Education: 
Marital Status: 
Occupation: 
No. of members in the family: 
Total Monthly Income: 
Age at first use of alcohol: 
Age at daily drinking: 
Family history of alcohol use: 
Other substance use: 
Withdrawal Symptoms: 
 Uncomlicated 
Complicated ,if any 
 
 
SEVERITY OF ALCOHOL DEPENDENCE QUESTITIONAIRE 
 
ngaH :       taJ :  Njjp : 
 
fle;j 6 khjq;fspy; kpf mjpfkhf mJ mUe;jpaij epidT $wTk;. 
vg;nghOJ?   khjk; :  tUlk; : 
 
cq;fspd; Fbg;gof;fk; Fwpj;j gpd;tUk; Nfs;tpfSf;F cq;fs; gjpy;fis tl;lkpl;L 
fhl;lTk;. 
kpf mjpfkhf kJ mUe;Jk; fhyq;fspy; : 
1 kJ mUe;jpa mLj;j ehs;  ehd; vOe;jpUf;Fk; NghJ mjpfkhf tpaHitia 
czHfpNwd;. 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
2 kJ mUe;jpa mLj;j ehs;   fhiy vOe;eTld; kd; iffs; eLq;Ftij 
czHfpNwd;. 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
3 kJ mUe;jpa mLj;j ehs;  kJ mUe;jtpy;iy vdpy; vdJ cly; kpfj; 
jPtpukhf eLq;Ftij czHfpNwd;. 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
4 kJ mUe;jpa mLj;j ehs; ehd; vOk; NghJ KOtJk; tpaHitapy; 
eide;jpUf;fpNwd;. 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
5 kJ mUe;jpa mLj;j ehs; fhiyapy; ngUk; gaj;Jld; vOe;jpUf;fpNwd; 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
6 kJ mUe;jpa mLj;j ehs;  fhiyapy; gpwiu re;jpf;Fk; NghJ gag;gLfpNwd; 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
 
 
7 kJ mUe;jpa mLj;j ehs; fhiyapy; vOk; NghJ ek;gpf;if ,y;yhjJ Nghy; 
czHfpNwd; 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
8 kJ mUe;jpa mLj;j ehs; fhiyapy; vOe;j gpd; gaj;ij czHfpNwd; 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
 
9 kJ mUe;jpa mLj;j ehs; kPz;Lk; fhiyapy; kJ mUe;j tpUk;GfpNwd; 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
10 kJ mUe;jpa mLj;j ehs;  kPz;Lk; kJ mUe;Jk; NghJ Kjypy; rpwpJ 
kJit kpf Ntfkhf tpOq;FfpNwd; 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
11 kJ mUe;jpa mLj;j ehs;  eLf;fj;ijF; Fiwg;gjw;fhf mjpf msT 
mUe;JfpNwd; 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
12 kJ mUe;jpa mLj;j ehs;  fhiyapy; vOk; NghJ kJtpd; kPJ MHtk; 
mjpfkhfpwJ 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
13 ehd; xU ehisf;F xU FthHl;lH rhuhak; (1 xapd; my.yJ 7 gPH) mjw;F 
Nky; Fbf;fpNwd; 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
14 ehd; xU ehisf;F miu ghl;by; rhuhak; (2 ghl;by; xapd; my.yJ 15 gPH) 
mjw;F Nky; Fbf;fpNwd; 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
15 ehd; xU ehisf;F xU ghl;by; rhuhak; (4 ghl;by; xapd; my.yJ 30 gPH) 
mjw;F Nky; Fbf;fpNwd; 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
 
 
 
16 ehd; xU ehisf;F 2 ghl;by; rhuhak; (8 ghl;by; xapd; my.yJ 60 gPH) 
mjw;F Nky; Fbf;fpNwd; 
 
vg;NghJk; ,y;iy vg;NghjhtJ      mbf;fb      vg;NghJk; 
 
gpd; tUk; epfo;Tfis fw;gid nra;aTk; 
 
1 ePq;fs; rpy thuq;fs; kJ mUe;Jtij Kw;wpYk; epWj;jp tpl;BHfs; 
2 mjw;F mLj;j 2 ehl;fs; kpf mjpfkhf kJ mUe;JfpwPHfs; 
3 ,uz;L ehl;fs; foe;jgpd; fhiyapy; vg;gb czHtPHfs;? 
 
17 vdf;F tpaHf;f Muk;gpf;Fk; 
xU NghJk; ,y;iy  nfhQ;rk;      kpjkhf  kpf mjpfkhf 
 
18 vdJ iffs; eLq;Fk; 
xU NghJk; ,y;iy  nfhQ;rk;      kpjkhf  kpf mjpfkhf 
 
19 vdJ cly; eLq;Fk; 
xU NghJk; ,y;iy  nfhQ;rk;      kpjkhf kpf mjpfkhf 
 
20 vdf;F kJtpd; kPJ jPtuk; mjpfhpf;Fk; 
xU NghJk; ,y;iy  nfhQ;rk;      kpjkhf kpf mjpfkhf 
 
DrInC 2R 
vg;nghOjhtJ fPNo nrhd;d khjphp cq;fSf;F ele;jpUf;fpwjh? 
   Mk; vdpy; 
Mk; ,y;iy xU Kiw 
my;yJ 
rpy Kiw 
thuk; 
xU 
Kiw 
jpdKk; 
1 Fbj;J Kbj;j gpwF jiy ghukhfTk;, 
f\;lkhfTk; ,Ue;jJ  
 
     
2 Fbj;j gpwF vdf;F ehNd kpfTk; 
tUj;jg;gl;bUf;fpNwd; 
     
3 Fbg;gof;fj;jpdhy; Ntiyf;F my;yJ 
gs;spf;F Nghfhky; ,Ue;jpUf;fpNwd;. 
 
     
4 vd;Dila FLk;gj;jpdHfs; my;yJ 
ez;gHfs; vd; Fbg;gof;fj;ij gw;wp  
ftiyg;gl;bUf;fpwhHfs; my;yJ GfhH 
nrhy;ypapUf;fpwhHfs;. 
 
     
5 ehd; gPH, xapd; Nghd;w kJtpd; Urpia  
mDgtpj;jpUf;fpNwd;. 
 
     
6 vd;Dila Fbg;gof;fj;jpdhy; vd; 
Ntiyapd; jpwd; ghjpf;fg;gl;bUf;fpwJ. 
     
7 ey;y ngw;NwhH Mf ,Uf;Fk; jFjp 
Fbg;gof;fj;jpdhy; 
ghjpf;fg;gl;bUf;fpwJ. 
     
8 Fbj;j gpwF vdf;F J}f;f njhe;juT, 
J}f;fkpd;ik, gaKs;s fdT 
,Ue;jpUf;fpwJ. 
 
     
9 ehd;  Fbj;J tpl;L tz;bia  
Xl;bapUf;fpNwd; 
 
     
10 kw;w Nghij kUe;Jfis 
gad;gLj;Jtjw;F 
vd;Dila Fbg;gof;fk; fhuzkhf 
,Ue;jpUf;fpwJ. 
 
     
11 Fbj;j gpwF NrhHTk; the;jpAk; vdf;F 
,Ue;jpUf;fpwJ. 
     
12 Fbg;gof;fj;jpdhy; re;Njhrkpd;ikahf 
,Uf;fpNwd;. 
     
13 Fbg;gof;fj;jpdhy; ehd; rhpahf 
rhg;gpLtjpy;iy. 
 
     
14 Fbg;gof;fj;jpdhy; (vd;dplkpUe;J) 
vjpHghHg;Gfis epiwNtw;w ,ayhky; 
,Ue;J ,Uf;fpNwd;. 
     
15 vdf;F kd ,Wf;fk; ,y;yhky; 
,Ug;gjw;F Fbg;gof;fk; cjtpaha; 
,Ue;jJ. 
     
16 Fbg;gof;fj;jpdhy; vdf;F Fw;w 
czHT my;yJ mtkhdkhf 
,Uf;fpwJ. 
     
17 Fbf;Fk; NghJ jiyFdpT, neUly; 
tUfpw khjphp NgrpapUf;fpNwd; my;yJ 
nra;jpUf;fpNwd;. 
     
18 Fbf;Fk; NghJ vd;Dila 
Fzhjpraq;fs; Nkhrkhd 
Fzhjpraq;fshf khwpaJ. 
     
19 Fbj;jpUf;Fk; NghJ  ehd; Mgj;jhd 
Kl;lhs;jdkhd KbTfis 
vLj;jpUf;fpNwd; 
     
20 Fbg;gjdhy; ehd; gpur;rpidapy; 
rpf;fpapUf;fpNwd; 
     
21 ehd; Fbj;jpUf;Fk; NghJ my;yJ 
Nghij nghUs; gad;gLj;Jk; NghJ 
kw;wtHfis fLikahf 
jpl;bapUf;fpNwd;. 
     
22 Fbf;Fk; NghJ ehd; Kd;Nahrid 
,y;yhky; nray;fs; nra;jjw;fhf 
tUj;jg;gl;L ,Uf;fpNwd;. 
     
23 Fbj;jpUf;Fk; NghJ   ehd; iffyg;G 
rz;ilfspy; <Lgl;bUf;fpNwd;. 
     
24 vd; Fbg;gof;fj;jpdhy; cly; 
MNuhf;fpak; ghjpf;fg;gl;Ltpl;lJ. 
     
25 Fbg;gof;fk; vd;  tho;f;if gw;wpa 
nuhk;g rhpahd fz;Nzhl;lk; 
ngWtjw;F cjtpahf ,Ue;jJ. 
     
26 Fbg;gof;fj;jpdhy;  vdf;F 
gzg;gpur;rpid ,Ue;jJ 
     
27 Fbg;gof;fj;jpdhy; vd;Dila fhjy; 
my;yJ jpUkz tho;f;if 
ghjpf;fg;gl;bUf;fpwJ 
     
28 ehd; Fbf;Fk; NghJ mjpfk;  Gif  
gpbf;fpNwd; 
     
29 Fbg;gof;fj;jpdhy;  vd;Dila cly; 
Njhw;wk; ghjpf;fg;gl;Lf; nfhz;L 
,Uf;fpwJ. 
     
30 Fbg;gof;fj;jpdhy;  vd; FLk;gk; 
ghjpj;J tpl;lJ. 
     
31 Fbg;gof;fj;jpdhy;  ez;gHfspd; cwT, 
neUf;fkhd cwTfs; ghjpj;Jtpl;lJ. 
     
32 Fbg;gof;fj;jpdhy;  vd;Dila cly;. 
vil mjpfhpj;Jtpl;lJ. 
     
33 Fbg;gof;fj;jpdhy;  vd; clYwT 
tho;f;if ghjpj;Jtpl;lJ 
     
34 Fbg;gof;fj;jpdhy;  vd;Dila 
nray;fspYk, ; nghOJNghf;F 
tpraq;fspYk;  MHtj;ij ,oe;J 
     
tpl;Nld; 
35 Fbj;jpUf;Fk; NghJ   vd; r%f 
tho;f;if kpfTk; re;Njhrkhf ,Ue;jJ. 
     
36 Fbg;gof;fj;jpdhy; vd;Dila Md;kPfk; 
kw;Wk; xOf;fKila tho;f;if 
ghjpj;Jtpl;lJ 
     
37 Fbg;gof;fk; ,Ug;gjhy; ehd; tpUk;gpa 
tho;f;if vdf;F fpilf;ftpy;iy. 
     
38 vd; kJg;gof;fk; vd; jdpg;gl;l  
tsHr;rpia ghjpj;Js;sJ 
     
39 vd; Fbg;gof;fk; vd; r%f tho;f;if, 
Gfo;, khpahijia nfLj;Jtpl;lJ. 
     
40 Fbg;gof;fj;jpdhy; ehd; epiwa 
gzj;ij nrytopj;Jtpl;Nld; my;yJ 
mjpfkhd gzj;ij ,oe;Jtpl;Nld; 
     
41 Fbj;Jtpl;L tz;b Xl;Lk; NghJ ehd; 
ifJ nra;ag;gl;bUf;fpNwd; 
     
42 Fbg;gof;fj;jpdhy; vdf;F rl;lg; 
gpur;rpid Vw;gl;bUf;fpwJ 
     
43 Fbg;gof;fj;jpdhy;  jpUkzk; fhjy; 
tho;f;ifia ,oe;J ,Uf;fpNwd; 
     
44 Fbg;gof;fj;jpdhy; ehd; 
NtiyapypUe;J my;yJ gs;spf;F 
NghfKbahky; jw;fhypf gzpePf;fk, ; 
epue;ju gzp ePf;fk; Vw;gl;bUf;fpwJ. 
     
45 ehd; ve;j gpur;rpidAk; ,y;yhky; kJ 
mUe;jpNdd; 
     
46 Fbg;gof;fj;jpdhy; ehd; ez;gHfis 
,oe;J ,Uf;fpNwd; 
     
47 ehd; Fbj;jpUf;Fk; NghJ vdf;F 
tpgj;J Vw;gl;L ,Uf;fpwJ. 
     
48 ehd; Nghijapy; ,Uf;Fk; NghJ 
clypy; 
fhak; my;yJ jPf; fhak; 
Vw;g;gl;Ls;sJ 
 
     
49 ehd; Nghijapy; ,Uf;Fk; NghJ 
vd;dhy; 
kw;wtHfSf;F fhak; Vw;gl;bUf;fpwJ. 
 
     
50 ehd; Fbj;J tpl;L Nghijapy; 
nghUl;fis cilj;J ,Uf;fpNwd; 
     
 
 
 
DrInC 2R SOM 
vg;nghOjhtJ fPNo nrhd;d khjphp cq;fSf;F ele;jpUf;fpwjh? 
   Mk; vdpy; 
Mk; ,y;iy xU Kiw 
my;yJ rpy 
Kiw 
thuk; 
xU 
Kiw 
jpdKk; 
1 Fbj;J Kbj;j gpwF mtUf;F jiy 
ghukhfTk;, f\;lkhfTk; ,Ue;jJ  
 
     
2 Fbg;gof;fj;jpdhy; Ntiyf;F my;yJ 
gs;spf;F Nghfhky; ,Ue;jpUf;fpwhH 
 
     
3 vd;Dila FLk;gj;jpdHfs; my;yJ 
ez;gHfs; mtUila Fbg;gof;fj;ij  
gw;wp ftiyg;gl;bUf;fpwhHfs; my;yJ  
GfhH nrhy;ypapUf;fpwhHfs;. 
 
     
4 mtUila Fbg;gof;fj;jpdhy; 
mtUila Ntiyapd; jpwd; 
ghjpf;fg;gl;bUf;fpwJ. 
     
5 ey;y ngw;NwhH Mf ,Uf;Fk; jFjp 
Fbg;gof;fj;jpdhy; 
ghjpf;fg;gl;bUf;fpwJ. 
     
6 mtH Fbj;J tpl;L tz;bia  
Xl;bapUf;fpwhH 
 
     
7 Fbj;j gpwF NrhHTk; the;jpAk; 
mtUf;F ,Ue;jpUf;fpwJ. 
     
8 Fbg;gof;fj;jpdhy; mtH rhpahf 
rhg;gpLtjpy;iy. 
 
     
9 Fbg;gof;fj;jpdhy; (vd;dplkpUe;J) 
vjpHghHg;Gfis epiwNtw;w ,ayhky; 
,Ue;J ,Uf;fpNwd;. 
     
10 Fbf;Fk; NghJ jiyFdpT, neUly; 
tUfpw khjphp NgrpapUf;fpwhH; my;yJ 
nra;jpUf;fpwhH. 
     
11 Fbf;Fk; NghJ mtUila 
Fzhjpraq;fs; Nkhrkhd 
Fzhjpraq;fshf khwpaJ. 
     
12 Fbj;jpUf;Fk; NghJ  mtH; Mgj;jhd 
Kl;lhs;jdkhd KbTfis 
vLj;jpUf;fpwhH 
     
13 Fbg;gjdhy; mtH gpur;rpidapy; 
rpf;fpapUf;fpwhH; 
     
14 mtH Fbj;jpUf;Fk; NghJ my;yJ 
Nghij nghUs; gad;gLj;Jk; NghJ 
kw;wtHfis fLikahf jpl;bapUf;fpwhH 
     
15 Fbf;Fk; NghJ mtH; Kd;Nahrid 
,y;yhky; nray;fs; nra;jjw;fhf 
     
tUj;jg;gl;L ,Uf;fpwhH 
16 Fbj;jpUf;Fk; NghJ   mtH; iffyg;G 
rz;ilfspy; <Lgl;bUf;fpwhH 
     
17 mtUila Fbg;gof;fj;jpdhy; cly; 
MNuhf;fpak; ghjpf;fg;gl;Ltpl;lJ. 
     
18 Fbg;gof;fj;jpdhy;  vdf;F 
gzg;gpur;rpid ,Ue;jJ 
     
19 Fbg;gof;fj;jpdhy; mtUila fhjy; 
my;yJ jpUkz tho;f;if 
ghjpf;fg;gl;bUf;fpwJ 
     
20 Fbg;gof;fj;jpdhy;  mtUila cly; 
Njhw;wk; ghjpf;fg;gl;Lf; nfhz;L 
,Uf;fpwJ. 
     
21 Fbg;gof;fj;jpdhy;  FLk;gk; ghjpj;J 
tpl;lJ. 
     
22 Fbg;gof;fj;jpdhy;  ez;gHfspd; cwT, 
neUf;fkhd cwTfs; ghjpj;Jtpl;lJ. 
     
23 Fbg;gof;fj;jpdhy;  mtUila cly;. 
vil mjpfhpj;Jtpl;lJ. 
     
24 Fbg;gof;fj;jpdhy;  mtUila 
nray;fspYk, ; nghOJNghf;F 
tpraq;fspYk;  MHtj;ij ,oe;J 
tpl;lhH 
     
25 mtUila Fbg;gof;fk; vd; r%f 
tho;f;if, Gfo;, khpahijia 
nfLj;Jtpl;lJ. 
     
26 Fbg;gof;fj;jpdhy; mtH; epiwa 
gzj;ij nrytopj;Jtpl;lhH; my;yJ 
mjpfkhd gzj;ij ,oe;Jtpl;lhH 
     
27 Fbj;Jtpl;L tz;b Xl;Lk; NghJ mtH 
ifJ nra;ag;gl;bUf;fpwhH 
     
28 Fbg;gof;fj;jpdhy; mtUf;F rl;lg; 
gpur;rpid Vw;gl;bUf;fpwJ 
     
29 Fbg;gof;fj;jpdhy;  jpUkzk; fhjy; 
tho;f;ifia ,oe;J ,Uf;fpwhH; 
     
30 Fbg;gof;fj;jpdhy; mtH; 
NtiyapypUe;J my;yJ gs;spf;F 
NghfKbahky; jw;fhypf gzpePf;fk, ; 
epue;ju gzp ePf;fk; Vw;gl;bUf;fpwJ. 
     
31 Fbg;gof;fj;jpdhy; mtH ez;gHfis 
,oe;J ,Uf;fpwhH 
     
32 mtH Fbj;jpUf;Fk; NghJ mtUf;F 
tpgj;J Vw;gl;L ,Uf;fpwJ. 
     
33 mtH Nghijapy; ,Uf;Fk; NghJ  
clypy; fhak; my;yJ jPf; fhak;  
Vw;g;gl;Ls;sJ 
 
     
34 mtH; Fbj;J tpl;L Nghijapy; 
nghUl;fis cilj;J ,Uf;fpwhH 
     
 
 
                       URICA 
 
Xt;nthU Nfs;tpf;Fk; fPNo cs;s Ie;J gjpy;fspy; xd;iw tl;lkplTk; 
 
1 ,e;j ikaj;jpw;F tUtjw;F cz;lhz fhuzk; vJTk; vdf;F ,y;yhjjhy;. 
,q;F jq;fp ,Uf;Fk; Neuk; tPzhdJ 
 1 jPtpu cld;ghl;by; ,y;iy   2 cld;ghL ,y;iy 
 3 KbT nra;a Kbatpy;iy   4 cld;gLfpNwd; 
 5 KOikahf  cld;gLfpNwd; 
 
2 vdf;F kdhPjpahfTk; czHT hPjpahfTk; kPz;Lk; gpur;rpidfs; cz;lhfhky; 
jLg;gjw;fhf ,e;j ikaj;jpy; ,Ug;gjhf fUJfpNwd;. 
 
1 jPtpu cld;ghl;by; ,y;iy   2 cld;ghL ,y;iy 
 3 KbT nra;a Kbatpy;iy   4 cld;gLfpNwd; 
 5 KOikahf  cld;gLfpNwd; 
 
3 vd;dplk; jtWfs; ,Uf;fyhk; vd;W fUjpdhYk; ehd; khw Ntz;baJ 
xd;Wkpy;iy. 
 1 jPtpu cld;ghl;by; ,y;iy   2 cld;ghL ,y;iy 
 3 KbT nra;a Kbatpy;iy   4 cld;gLfpNwd; 
 5 KOikahf  cld;gLfpNwd; 
 
4 ehd; khWtjw;fhf kpf fbdkhf Kaw;rp nra;fpNwd; 
 1 jPtpu cld;ghl;by; ,y;iy   2 cld;ghL ,y;iy 
 3 KbT nra;a Kbatpy;iy   4 cld;gLfpNwd; 
 5 KOikahf  cld;gLfpNwd; 
 
5 vdf;F kdhPjpahfTk; czHT hPjpahfTk;  gpur;rpidfs; cz;L vd;Wk; 
mijg;gw;wp KO  Ma;T  Njit vd;Wk; czHfpNwd; 
 1 jPtpu cld;ghl;by; ,y;iy   2 cld;ghL ,y;iy 
 3 KbT nra;a Kbatpy;iy   4 cld;gLfpNwd; 
 5 KOikahf  cld;gLfpNwd; 
 
6 ehd; vd;id czHtjw;F Jiz nra;Ak; vd;W ek;GfpNwd; 
 1 jPtpu cld;ghl;by; ,y;iy   2 cld;ghL ,y;iy 
 3 KbT nra;a Kbatpy;iy   4 cld;gLfpNwd; 
 5 KOikahf  cld;gLfpNwd; 
 
 7 ehd; kdhPjpahfTk czHT hPjpahfTk; ,Uf;Fk; gpur;rpidfSf;F jPHT fhZk; 
NghJ mg;gpur;rpidapy; ,Ue;J tpLgl;L tpl;ljhf fUjpdhYk;.  me;j 
gpur;rpidapNyNa kPz;Lk; rpf;fp jtpf;fpNwd; 
 1 jPtpu cld;ghl;by; ,y;iy   2 cld;ghL ,y;iy 
 3 KbT nra;a Kbatpy;iy   4 cld;gLfpNwd; 
 5 KOikahf  cld;gLfpNwd; 
 
8 ,e;j ikak; vdf;F cjtp nra;Ak; vd;W czUfpNwd; 
 1 jPtpu cld;ghl;by; ,y;iy   2 cld;ghL ,y;iy 
 3 KbT nra;a Kbatpy;iy   4 cld;gLfpNwd; 
 5 KOikahf  cld;gLfpNwd; 
 
9 ,e;j gpur;rpidfspd; xU gFjpf;F ehd; fhuzkhf ,Uf;fyhk; vd;whYk;. ehd; 
mg;gb rpe;jpf;ftpy;iy. 
 1 jPtpu cld;ghl;by; ,y;iy   2 cld;ghL ,y;iy 
 3 KbT nra;a Kbatpy;iy   4 cld;gLfpNwd; 
 5 KOikahf  cld;gLfpNwd; 
 
10 khWtijg; gw;wp ahUk; NgRtJ Rygk; MapDk; khw Ntz;Lk; vd;gjw;fhf 
rpytw;iw ehd; nra;J nfhz;L ,Uf;fpNwd; 
 1 jPtpu cld;ghl;by; ,y;iy   2 cld;ghL ,y;iy 
 3 KbT nra;a Kbatpy;iy   4 cld;gLfpNwd; 
 5 KOikahf  cld;gLfpNwd; 
 
11 kdhPjpahfTk czHT hPjpahfTk; Vw;gl;l gpur;rpidfspy; ,Ue;J tpLgl;ljhf 
fUjpa Neuj;jpy; me;jg; gpur;rpidfspy; kPz;Lk; rpf;fp tpLNtd; vd;W epidf;Fk; 
NghJ tho;f;if kPJ ntWg;G Njhd;WfpwJ. 
 1 jPtpu cld;ghl;by; ,y;iy   2 cld;ghL ,y;iy 
 3 KbT nra;a Kbatpy;iy   4 cld;gLfpNwd; 
 5 KOikahf  cld;gLfpNwd; 
 
12 kdhPjpahfTk czHT hPjpahfTk; Vw;gLk; gpur;rpidfspy; ,Ue;J tpLgl ehd; 
kpfTk; jPtpukhf Kaw;rp nra;fpNwd;. 
 1 jPtpu cld;ghl;by; ,y;iy   2 cld;ghL ,y;iy 
 3 KbT nra;a Kbatpy;iy   4 cld;gLfpNwd; 
 5 KOikahf  cld;gLfpNwd; 
 
